BET inhibition as a new strategy for the treatment of gastric cancer

Gastric cancer is one of the most common malignancies and a leading cause of cancer death worldwide. The prognosis of stomach cancer is generally poor as this cancer is not very sensitive to commonly used chemotherapies. Epigenetic modifications play a key role in gastric cancer and contribute to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Montenegro, Raquel C., Clark, Peter G.K., Howarth, Alison, Wan, Xiao, Ceroni, Alessandro, Siejka, Paulina, Nunez-Alonso, Graciela A., Monteiro, Octovia, Rogers, Catherine, Gamble, Vicki, Burbano, Rommel, Brennan, Paul E., Tallant, Cynthia, Ebner, Daniel, Fedorov, Oleg, O'Neill, Eric, Knapp, Stefan, Dixon, Darren, Müller, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190074/
https://www.ncbi.nlm.nih.gov/pubmed/27259267
http://dx.doi.org/10.18632/oncotarget.9766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190074/
https://www.ncbi.nlm.nih.gov/pubmed/27259267
http://dx.doi.org/10.18632/oncotarget.9766

Ejemplares similares